Bring your next study to Boeson Research

Select specialty investigators and community-based research sites across Montana and Utah. Bring us one protocol—or a program that needs more than one Boeson site.

Find investigator and location fit

Connect your protocol with clinical expertise across Montana and Utah. Our investigators bring experience in women’s health, metabolic disease, cardiology, psychiatry, rheumatology, dermatology, vaccines, nephrology and neuropsychology.

Compare investigator backgrounds and local expertise, then request a focused response for the sites that fit your program.

One program. More than one Boeson site.

Build your site shortlist around complementary investigators in Montana and Utah. Ask Boeson to evaluate two or more locations for the same protocol, or match different specialties to studies across your development program.

Request a site-by-site response covering investigator fit, recruitment approach, procedures and startup needs. Each location is evaluated against your protocol, so you can select the strongest combination.

Request a multi-site feasibility review

Build your study with Boeson

Investigator and population

Match your population and protocol with relevant investigator experience and a location-specific recruitment approach.

Visit delivery

Build the visit plan around your protocol’s staffing, procedures, equipment and participant needs.

Data and oversight

We discuss source records, data-entry expectations, monitoring access, and communication responsibilities.

Startup planning

We identify document, training, budget, contract, and activation requirements.

Research systems and pre-screening

Boeson uses RealTime CTMS and electronic research records. Research submissions are handled through designated research systems, separately from general website contact messages. Protocol-specific workflows, access, and data requirements are discussed during startup.

Boeson’s Master Pre-Screening and Screening Plausibility Protocol, BR-REC-001 Version 1.1 dated September 14, 2026, was approved by Pearl IRB under IRB ID 2026-0457. This framework supports permission-based preliminary assessment. It does not establish trial eligibility, replace study-specific consent, or approve unrelated recruitment materials.

Privacy Statement

Start site selection with Boeson

Share a nonconfidential outline of your study, the population, proposed locations, key procedures, and expected timeline. We can then discuss the relevant investigator, staffing, facility, and operational requirements.

Tell us whether you are selecting one site or several. Include your key population criteria, enrollment objectives and specialized procedures so our response addresses the decisions your evaluation team needs to make.